Edited on Jul 1, 2026.
Bayer, the German pharmaceutical and life-sciences company, spent two years moving its digital media buying in-house, replacing work previously routed through agency contracts. It saved tens of millions of dollars. It redirected the dollars into digital execution. The cost story is the one the trade press ran with. The control story is the one that mattered more — and Bayer's move sat inside a broader structural shift in how the largest advertisers operate that has continued to compound through the six years since.
This is the account of what Bayer did, why it did it, what the results were, and what the broader in-housing pattern means for the marketing services industry going forward.
What Bayer actually did
Bayer's in-housing program ran from roughly 2018 through 2020. The scope was structural, not tactical: rather than firing its agencies and starting over, Bayer built an internal digital media buying capability and then renegotiated the agency relationships around it. The internal team took direct ownership of programmatic media purchasing across Bayer's consumer health and pharmaceutical divisions, of the ad-tech relationships with Google, The Trade Desk, and the walled-garden platforms, and of the first-party data infrastructure that fed the buying decisions.
The reported outcomes were substantial. Bayer disclosed tens of millions of dollars in annual cost savings from the agency-margin capture alone. The savings were largely redirected into working digital media rather than returned as budget reductions — the internal capability generated more advertising output per dollar rather than the same output for less.
The precedent behind the move was Procter & Gamble. Marc Pritchard, P&G's Chief Brand Officer, had used his January 2017 Interactive Advertising Bureau keynote to publicly challenge the digital advertising supply chain on transparency, viewability, and agency-margin opacity. P&G subsequently moved substantial portions of its own marketing capability in-house and cut its agency roster. Bayer was one of the first European multinationals to follow the P&G template at material scale.
The real argument for in-housing
Four operating advantages compound when marketing capability sits inside the company rather than at an agency.
Speed on regulated communications. Pharmaceutical marketing lives or dies on compliance. Compliance lives or dies on speed. Approval cycles that take weeks through an external agency — because every draft has to move between the brand team, the agency creative team, medical-legal-regulatory review, and back — can take hours inside the building, with regulatory and legal sitting in the same room as the creative team. For a regulated advertiser, the speed differential alone justifies the investment.
Direct control of first-party data. The 2018–2024 transition off third-party cookies made first-party data the strategic asset in digital marketing. Companies that own their own customer data, their own site behavior signals, and their own CRM audiences have leverage that companies routing everything through agency middleware do not. In-housing brings the data infrastructure under company control.
Transparency on media spend. The 2016 Association of National Advertisers report on media transparency documented systematic non-transparent business practices inside the agency-holding-company media system — undisclosed rebates from media owners, principal buying arrangements, undisclosed markups on programmatic. In-housing eliminates the layer where the non-transparent practices lived.
Creative ownership. Brands with strong in-house creative teams — Nike, Apple, Airbnb — have consistently produced sharper, faster, and more brand-consistent creative than brands operating exclusively through agency relationships. The creative-control argument is separate from the media-buying argument but often travels with it inside the same in-housing program.
The cost argument is real. The four control arguments are structurally larger.
The broader in-housing pattern
Bayer is one entry in a long list. The largest advertisers globally have moved meaningful portions of their marketing operations in-house across the past decade.
Procter & Gamble. The template. Marc Pritchard's transparency campaign and the subsequent restructuring of P&G's agency relationships. Consolidated agency roster. In-house creative through P&G's Studio X. Internal media capability across multiple brand groups.
Unilever. Built the U-Studio in-house content operation to produce brand and product content at global scale. Consolidated agency roster substantially. Retains external agencies for specialist creative and multi-market campaigns.
Anheuser-Busch InBev. Draftline, ABI's in-house creative operation, has produced Super Bowl work and category-defining brand campaigns. Marcel Marcondes and the ABI marketing leadership have positioned in-house capability as strategic infrastructure rather than a cost-savings program.
PepsiCo. Content Studio internal operation, in-house media capabilities, and consolidated external agency relationships.
Vodafone, Deutsche Telekom, and multiple European telecom operators. In-house media buying, in-house creative for BAU work, external agencies for major campaigns.
Netflix, Meta, Amazon, and Alphabet. The technology companies have operated their marketing primarily in-house from inception, in part because their data and platform-integration requirements made external agencies structurally impractical.
The trade-offs — what in-housing gives up
Every in-housing program runs into the same three constraints.
Talent depth on specialist disciplines. Building an in-house team that matches agency depth on programmatic buying, brand strategy, regulated-industry creative, and platform-specific media capabilities is expensive and slow. Most in-housing programs end up with senior talent gaps that require either aggressive recruiting or continued external relationships.
Cyclical flexibility. External agencies scale up and down with the marketing calendar. In-house teams do not. Companies that in-house their full marketing capability lose the flexibility to surge on major campaigns and scale down between them. The result: most in-housing programs settle into a hybrid model — in-house core for BAU, external agencies for surge and specialist work.
Category perspective. Agencies work across multiple clients in a category and see patterns that in-house teams do not. A pharmaceutical brand team inside Bayer sees Bayer. An agency creative director serving Bayer, Pfizer, Merck, and Roche sees the pharmaceutical category. That cross-client pattern recognition is a structural advantage the agencies retain regardless of how much of the executional work moves in-house.
The hybrid is the settled model
Six years after Bayer's move, the industry has settled into a hybrid model as the dominant operating structure at the largest advertisers. In-house teams own the day-to-day execution, the first-party data infrastructure, the platform relationships, and the fast-turnaround creative. External agencies are retained for specialist creative, brand-strategy engagements, multi-market campaigns, surge capacity around launches, and the work that requires senior senior talent the company would not retain full-time.
The consequence for the agency world: the agencies that survive the shift are the ones that solve problems the in-house team cannot solve alone. Volume execution work — the bread-and-butter of the agency-holding-company networks for decades — has been progressively absorbed by client in-house teams. The senior specialist work has become more valuable, and the firms operating at that senior tier have grown at the expense of the mid-tier volume shops.
The AI Communications implication
The in-housing pattern intersects with the AI Communications shift in ways that will shape the next cycle.
AI answer engines are a new discovery surface. Brands that want to be present inside ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews need to build content, entity architecture, and citation footprints that the engines will retrieve. That work sits partly inside earned media, partly inside content, partly inside SEO, and partly inside Generative Engine Optimization (GEO) — a discipline that did not exist five years ago.
In-house teams are not yet built for GEO at most companies. The measurement — Citation Share across a defined query set — is not yet standard inside client analytics stacks. The agency firms that are building AI Communications capability are moving into a specialist lane that in-house teams will need years to develop. The next iteration of the agency-client boundary will be defined by which side owns the AI-visibility work — and, in the near term, most of it will sit outside the client's in-house team.
Why Bayer's move was a tell
Companies that bring marketing in-house are signaling something simple: the function is too strategic to outsource end-to-end. The value chain in marketing has shifted such that owning the data, owning the platform relationships, and owning the executional cadence produces compounding advantages over time. Bayer's move looked like a media story. It was a structural one — about where strategic capability sits inside a company, and how much of the marketing function can be treated as a service to procure versus a core competency to own.
The next question for every large advertiser is what stays in-house and what does not. AI Communications is the most likely answer to what does not — at least through the current cycle.
